Intellectual property law and access to medicines: TRIPS Agreement, health, and pharmaceuticals
"The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - s...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Milton Park, Abingdon, Oxon ; New York, NY
Routledge
[2021]
|
| Schriftenreihe: | Law, development and globalization
|
| Schlagworte: | |
| Zusammenfassung: | "The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - such as states, transnational business corporations or civil society groups - and their influence on the structures - such as national and international agreements, organizations and private entities - that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade and TRIPS, as it galvanized non-state and non-business actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to life-saving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors and others with relevant concerns working in non-governmental and international organizations"-- |
| Beschreibung: | xviii, 503 Seiten Illustrationen 24 cm |
| ISBN: | 9780367436384 9781032009704 |
Internformat
MARC
| LEADER | 00000nam a22000008c 4500 | ||
|---|---|---|---|
| 001 | BV047391191 | ||
| 003 | DE-604 | ||
| 005 | 20220427 | ||
| 007 | t | ||
| 008 | 210729s2021 a||| b||| 00||| eng d | ||
| 020 | |a 9780367436384 |c hbk |9 978-0-367-43638-4 | ||
| 020 | |a 9781032009704 |c pbk |9 978-1-032-00970-4 | ||
| 035 | |a (OCoLC)1310252305 | ||
| 035 | |a (DE-599)BVBBV047391191 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-703 |a DE-19 | ||
| 084 | |a PT 335 |0 (DE-625)139869: |2 rvk | ||
| 245 | 1 | 0 | |a Intellectual property law and access to medicines |b TRIPS Agreement, health, and pharmaceuticals |c edited by Srividhya Ragavan and Amaka Vanni |
| 264 | 1 | |a Milton Park, Abingdon, Oxon ; New York, NY |b Routledge |c [2021] | |
| 300 | |a xviii, 503 Seiten |b Illustrationen |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Law, development and globalization | |
| 505 | 8 | |a Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- | |
| 505 | 8 | |a Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- | |
| 505 | 8 | |a The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni | |
| 520 | 3 | |a "The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - such as states, transnational business corporations or civil society groups - and their influence on the structures - such as national and international agreements, organizations and private entities - that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade and TRIPS, as it galvanized non-state and non-business actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to life-saving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors and others with relevant concerns working in non-governmental and international organizations"-- | |
| 630 | 0 | 7 | |a Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum |f 1994 April 15 |0 (DE-588)4450013-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Drugs / Patents | |
| 653 | 0 | |a Drug accessibility / Law and legislation | |
| 653 | 0 | |a Foreign trade regulation / Health aspects | |
| 653 | |a Agreement on Trade-Related Aspects of Intellectual Property Rights / (1994 April 15) | ||
| 653 | 0 | |a Patents (International law) | |
| 653 | |a Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15) | ||
| 653 | 0 | |a Drug accessibility / Law and legislation | |
| 653 | 0 | |a Drugs / Patents | |
| 653 | 0 | |a Patents (International law) | |
| 689 | 0 | 0 | |a Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum |f 1994 April 15 |0 (DE-588)4450013-0 |D u |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Ragavan, Srividhya |0 (DE-588)1245940317 |4 edt | |
| 700 | 1 | |a Vanni, Amaka |0 (DE-588)1210311208 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-003-17660-2 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032792515 | ||
Datensatz im Suchindex
| _version_ | 1804182644638875648 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Ragavan, Srividhya Vanni, Amaka |
| author2_role | edt edt |
| author2_variant | s r sr a v av |
| author_GND | (DE-588)1245940317 (DE-588)1210311208 |
| author_facet | Ragavan, Srividhya Vanni, Amaka |
| building | Verbundindex |
| bvnumber | BV047391191 |
| classification_rvk | PT 335 |
| contents | Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni |
| ctrlnum | (OCoLC)1310252305 (DE-599)BVBBV047391191 |
| discipline | Rechtswissenschaft |
| discipline_str_mv | Rechtswissenschaft |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05900nam a22005298c 4500</leader><controlfield tag="001">BV047391191</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220427 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210729s2021 a||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780367436384</subfield><subfield code="c">hbk</subfield><subfield code="9">978-0-367-43638-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781032009704</subfield><subfield code="c">pbk</subfield><subfield code="9">978-1-032-00970-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1310252305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047391191</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PT 335</subfield><subfield code="0">(DE-625)139869:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intellectual property law and access to medicines</subfield><subfield code="b">TRIPS Agreement, health, and pharmaceuticals</subfield><subfield code="c">edited by Srividhya Ragavan and Amaka Vanni</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Milton Park, Abingdon, Oxon ; New York, NY</subfield><subfield code="b">Routledge</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xviii, 503 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Law, development and globalization</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - such as states, transnational business corporations or civil society groups - and their influence on the structures - such as national and international agreements, organizations and private entities - that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade and TRIPS, as it galvanized non-state and non-business actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to life-saving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors and others with relevant concerns working in non-governmental and international organizations"--</subfield></datafield><datafield tag="630" ind1="0" ind2="7"><subfield code="a">Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum</subfield><subfield code="f">1994 April 15</subfield><subfield code="0">(DE-588)4450013-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Patents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug accessibility / Law and legislation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Foreign trade regulation / Health aspects</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Agreement on Trade-Related Aspects of Intellectual Property Rights / (1994 April 15)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Patents (International law)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug accessibility / Law and legislation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Patents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Patents (International law)</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum</subfield><subfield code="f">1994 April 15</subfield><subfield code="0">(DE-588)4450013-0</subfield><subfield code="D">u</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ragavan, Srividhya</subfield><subfield code="0">(DE-588)1245940317</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vanni, Amaka</subfield><subfield code="0">(DE-588)1210311208</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-003-17660-2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032792515</subfield></datafield></record></collection> |
| id | DE-604.BV047391191 |
| illustrated | Illustrated |
| index_date | 2024-07-03T17:50:05Z |
| indexdate | 2024-07-10T09:10:50Z |
| institution | BVB |
| isbn | 9780367436384 9781032009704 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032792515 |
| oclc_num | 1310252305 |
| open_access_boolean | |
| owner | DE-M382 DE-703 DE-19 DE-BY-UBM |
| owner_facet | DE-M382 DE-703 DE-19 DE-BY-UBM |
| physical | xviii, 503 Seiten Illustrationen 24 cm |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Routledge |
| record_format | marc |
| series2 | Law, development and globalization |
| spelling | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals edited by Srividhya Ragavan and Amaka Vanni Milton Park, Abingdon, Oxon ; New York, NY Routledge [2021] xviii, 503 Seiten Illustrationen 24 cm txt rdacontent n rdamedia nc rdacarrier Law, development and globalization Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni "The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - such as states, transnational business corporations or civil society groups - and their influence on the structures - such as national and international agreements, organizations and private entities - that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade and TRIPS, as it galvanized non-state and non-business actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to life-saving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors and others with relevant concerns working in non-governmental and international organizations"-- Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Drugs / Patents Drug accessibility / Law and legislation Foreign trade regulation / Health aspects Agreement on Trade-Related Aspects of Intellectual Property Rights / (1994 April 15) Patents (International law) Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15) Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 u Arzneimittel (DE-588)4003115-9 s DE-604 Ragavan, Srividhya (DE-588)1245940317 edt Vanni, Amaka (DE-588)1210311208 edt Erscheint auch als Online-Ausgabe 978-1-003-17660-2 |
| spellingShingle | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4450013-0 (DE-588)4003115-9 |
| title | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals |
| title_auth | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals |
| title_exact_search | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals |
| title_exact_search_txtP | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals |
| title_full | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals edited by Srividhya Ragavan and Amaka Vanni |
| title_fullStr | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals edited by Srividhya Ragavan and Amaka Vanni |
| title_full_unstemmed | Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals edited by Srividhya Ragavan and Amaka Vanni |
| title_short | Intellectual property law and access to medicines |
| title_sort | intellectual property law and access to medicines trips agreement health and pharmaceuticals |
| title_sub | TRIPS Agreement, health, and pharmaceuticals |
| topic | Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 Arzneimittel |
| work_keys_str_mv | AT ragavansrividhya intellectualpropertylawandaccesstomedicinestripsagreementhealthandpharmaceuticals AT vanniamaka intellectualpropertylawandaccesstomedicinestripsagreementhealthandpharmaceuticals |